arrow
M

Mark A. Tomai

3m
H指数:50
被引数:8,532

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Optimizing immunogenicity and product presentation of a SARS-CoV-2 subunit vaccine composition: effects of delivery route, heterologous regimens with self-amplifying RNA vaccines, and lyophilization
2024-12-160
OAAI
Comparison of the immunogenicity of mRNA-encoded and protein HIV-1 Env-ferritin nanoparticle designs
2024-09-171
PRE
Use of 3M-052-AF with Alum adjuvant in HIV trimer vaccine induces human autologous neutralizing antibodies
2024-09-051
PRE
Immunogenicity and safety of an Entamoeba histolytica adjuvanted protein vaccine candidate (LecA+GLA-3M-052 liposomes) in rhesus macaques
2024-08-011
OAAI
A comparative immunological assessment of multiple clinical-stage adjuvants for the R21 malaria vaccine in nonhuman primates

非人灵长类动物R21疟疾疫苗的多种临床阶段佐剂的比较免疫学评估

2024-07-310
PRE
Intradermal but not intramuscular modified vaccinia Ankara immunizations protect against intravaginal tier2 simian-human immunodeficiency virus challenges in female macaques

皮内但非肌内改良的安卡拉牛痘免疫接种可防止雌性猕猴的阴道内tier2猿猴-人类免疫缺陷病毒挑战

2023-08-084
OAAI
Infant rhesus macaques immunized against SARS-CoV-2 are protected against heterologous virus challenge 1 year later
2023-03-0112
OAAI
Breadth of SARS-CoV-2 neutralization and protection induced by a nanoparticle vaccine
2022-10-2336
OAAI
Stabilized HIV-1 envelope immunization induces neutralizing antibodies to the CD4bs and protects macaques against mucosal infection
2022-09-0718
OA
Efficacy of pediatric SARS-CoV-2 vaccines against high-dose B.1.617.2 challenge one year after vaccination of infant rhesus macaques
2022-05-010
PRE
A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates
2021-07-2961
OA
Optimizing a Multi-Component Intranasal Entamoeba Histolytica Vaccine Formulation Using a Design of Experiments Strategy
2021-06-2515
OAAI
SARS-CoV-2 vaccines elicit durable immune responses in infant rhesus macaques
2021-06-1533
OAAI
SARS-CoV-2 RBD trimer protein adjuvanted with Alum-3M-052 protects from SARS-CoV-2 infection and immune pathology in the lung
2021-06-1175
OAAI
3M-052, a synthetic TLR-7/8 agonist, induces durable HIV-1 envelope-specific plasma cells and humoral immunity in nonhuman primates
2020-06-26101
OAAI